These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32281237)
21. Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors. Kim BK; Choe SJ; Chung HC; Oh SS; Lee WS Int J Dermatol; 2018 Feb; 57(2):183-192. PubMed ID: 29330930 [TBL] [Abstract][Full Text] [Related]
22. Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans. Park SY; Oh SS; Lee WS J Dermatol; 2016 Nov; 43(11):1293-1300. PubMed ID: 27028221 [TBL] [Abstract][Full Text] [Related]
23. Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk. Ertas R; Orscelik O; Kartal D; Dogan A; Ertas SK; Aydogdu EG; Ascioglu O; Borlu M Blood Press; 2016 Jun; 25(3):141-8. PubMed ID: 26585114 [TBL] [Abstract][Full Text] [Related]
24. Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years. Descamps V; Mahé E; Maccari F; Begon E; Barthelemy H; Reguiai Z; Bénéton N; Estève E; Chaby G; Ruer-Mulard M; Steiner HG; Thomas-Beaulieu D; Avenel-Audran M; Goujon-Henry C; Sigal ML; Ezzedine K; Beauchet A; Eur J Dermatol; 2014; 24(3):356-60. PubMed ID: 24979347 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the relationship between serum G protein-coupled estrogen receptors (GPER-1) levels and the severity and duration of the disease in patients with androgenetic alopecia: A case-control study. Kuş MM; Düzenli ZB; Öztürk P; Kurutas EB Arch Dermatol Res; 2024 Oct; 316(9):658. PubMed ID: 39369050 [TBL] [Abstract][Full Text] [Related]
26. Androgenetic alopecia in policemen: higher prevalence and different risk factors relative to the general population (KCIS no. 23). Su LH; Chen HH Arch Dermatol Res; 2011 Dec; 303(10):753-61. PubMed ID: 21927906 [TBL] [Abstract][Full Text] [Related]
28. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study. Tabolli S; Sampogna F; di Pietro C; Mannooranparampil TJ; Ribuffo M; Abeni D Am J Clin Dermatol; 2013 Apr; 14(2):139-45. PubMed ID: 23413102 [TBL] [Abstract][Full Text] [Related]
29. Higher plasma leptin is associated with higher risk of androgenetic alopecia in men. Yang CC; Chung PL; Lin LY; Hughes MW; Tsai YS Exp Dermatol; 2017 Jun; 26(6):524-526. PubMed ID: 28423238 [TBL] [Abstract][Full Text] [Related]
30. Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients. Özcan D An Bras Dermatol; 2022; 97(2):166-172. PubMed ID: 35033390 [TBL] [Abstract][Full Text] [Related]
31. Patients with a large prostate show a higher prevalence of androgenetic alopecia. Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of early-onset androgenetic alopecia and its relationship with lifestyle and dietary habits. Agaoglu E; Kaya Erdogan H; Acer E; Atay E; Metintas S; Saracoglu ZN Ital J Dermatol Venerol; 2021 Dec; 156(6):675-680. PubMed ID: 33913667 [TBL] [Abstract][Full Text] [Related]
33. Androgenetic alopecia and coronary artery disease in women. Mansouri P; Mortazavi M; Eslami M; Mazinani M Dermatol Online J; 2005 Dec; 11(3):2. PubMed ID: 16409898 [TBL] [Abstract][Full Text] [Related]
34. Increase in subcutaneous adipose tissue in the frontal scalp may be associated with androgenetic alopecia and metabolic syndrome. Dayanan R; Bilen A; Çiftel S; Çiftel E; Mercantepe F; Demirci T; Tonkaz G; Yakar B; Önalan E; Çapoğlu I; Bilen H Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5748-5756. PubMed ID: 37401311 [TBL] [Abstract][Full Text] [Related]
35. A cross sectional study evaluating the relationship of acne to androgenetic alopecia subtype and severity. Özkoca D; Kazan D; Gencebay G; Caf N; Kara Esen B; Oba MÇ Arch Dermatol Res; 2024 Aug; 316(8):533. PubMed ID: 39154095 [TBL] [Abstract][Full Text] [Related]
36. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Severi G; Sinclair R; Hopper JL; English DR; McCredie MR; Boyle P; Giles GG Br J Dermatol; 2003 Dec; 149(6):1207-13. PubMed ID: 14674898 [TBL] [Abstract][Full Text] [Related]
37. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Hirsso P; Laakso M; Matilainen V; Hiltunen L; Rajala U; Jokelainen J; Keinänen-Kiukaanniemi S Cent Eur J Public Health; 2006 Jun; 14(2):78-81. PubMed ID: 16830609 [TBL] [Abstract][Full Text] [Related]
38. [Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels]. Ságodi L; Fehér V; Kiss-Tóth E; Almási A; Barkai L Orv Hetil; 2015 May; 156(22):888-95. PubMed ID: 26004548 [TBL] [Abstract][Full Text] [Related]
39. Serum Ferritin Levels amongst Individuals with Androgenetic Alopecia in Ile-Ife, Nigeria. Enitan AO; Olasode OA; Onayemi EO; Ajani AA; Olanrewaju FO; Oripelaye MM; Oninla OA; Akinboro AO West Afr J Med; 2022 Oct; 39(10):1026-1031. PubMed ID: 36260427 [TBL] [Abstract][Full Text] [Related]